Memantine ER capsules: Package Insert / Prescribing Info - Drugs.com
Memantine hydrochloride extended-release capsules are a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. (1) Memantine hydrochloride extended-release capsule is available as an extended-release capsule in the following strengths: 7 mg, 14 mg, 21 mg, 28 mg (3)
Memantine (Namenda) - Uses, Side Effects, and More - WebMD
2024年6月27日 · Memantine is commonly used to treat moderate to severe dementia related to Alzheimer’s disease. Memantine may also be used for other conditions as determined by your healthcare provider.
Memantine: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年7月5日 · The maximum dose of memantine for people with severe kidney disease is 5mg twice daily. Extended-release capsules. The usual starting dose of memantine extended-release capsules is 7 mg once daily. The dose should be increased in 7 mg increments to the recommended maintenance dose of 28 mg once daily.
Memantine hydrochloride extended-release capsule is a prescription medicine used for the treatment of moderate to severe dementia in people with Alzheimer’s disease. Memantine hydrochloride extended-release capsule belongs to a class of medicines called N-methyl-D-aspartate(NMDA) inhibitors.
Memantine ER Tablets: Package Insert / Prescribing Info - Drugs.com
2024年3月25日 · Memantine hydrochloride tablets, USP are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. (1) Initial dose is 5 mg once daily. Increase dose in 5 mg increments to a maintenance dose of 10 mg twice daily.
See full prescribing information for NAMENDA XR capsules. NAMENDA XR contains memantine HCl, an NMDA receptor antagonist indicated for the treatment of moderate to severe dementia of the...
Memantine extended release (28 mg once daily): a review of its ... - PubMed
Memantine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that is a well-established treatment option for moderate to severe dementia of the Alzheimer's type, either alone or in combination with cholinesterase inhibitors. The immediate-release (IR) formulations of memantine (tabl …
Memantine HCL ER 28mg Capsules - HealthWarehouse
MEMANTINE EXTENDED-RELEASE - ORAL. (MEM-an-teen) COMMON BRAND NAME (S): Namenda XR. USES: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer\'s disease. It does not cure Alzheimer\'s disease, but it may improve memory, awareness, and the ability to perform daily functions.
memantine ER 7 mg-14 mg-21 mg-28 mg capsule ... - Kaiser Permanente
Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions.
Memantine: MedlinePlus Drug Information
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain.
- 某些结果已被删除